Latest Actelion Ltd (ALIOF) Headlines Myriad Genetics

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Actelion Ltd (ALIOF) Headlines

Myriad Genetics Up on Prolaris Data; Aims Reimbursement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 1:50PM CST
Recently, favorable data from Myriad Genetics' PROCEDE 500 study was published in the journal Current Medical Research and Opinion.

Actelion Gains on QIDP and Fast Track Status - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 4:10PM CST
Shares of Actelion gained 4.7% on the announcement of the receipt of QIDP and Fast Track designations for its CDAD candidate, cadazolid.

Transition Therapeutics (TTHI) Jumps: Stock Moves 7.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 8:46AM CST
Transition Therapeutics was a big mover last session, with shares rising nearly 8%.

UCB Misses Earnings Ests, Revs In Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 12:32PM CST
UCB reported 2013 earnings per share of $2.56, missed the Zacks Consensus Estimate of $2.84.

Shares Fall as Aegerion Posts Wider-than-Expected Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 12:26PM CST
Aegerion Pharma reported 4Q13 net loss per share of 47 cents, wider than the Zacks Consensus Estimate of a loss of 28 cents

Actelion's novel antibiotic cadazolid receives US FDA Qualified Infectious Disease Product designation for the treatment of Clostridium difficile-associated diarrhea
Thomson Reuters ONE - Thu Feb 27, 10:35AM CST
Actelion Pharmaceuticals Ltd / Actelion's novel antibiotic cadazolid receives US FDA Qualified Infectious Disease Product designation for the treatment of Clostridium difficile-associated diarrhea . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Encouraging News from Pfizer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 4:25PM CST
Pfizer recently released encouraging top-line results from a randomized, placebo-controlled trial, CAPiTA on pneumonia vaccine Prevenar 13

NewLink Genetics (NLNK) Jumps: Stock Moves 8.2% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:46AM CST
NewLink Genetics was a big mover last session, with shares rising over 8%.

Synta Pharmaceuticals (SNTA) Catches Eye: Stock Rises 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:25AM CST
Synta Pharmaceuticals was a big mover last session, with shares rising nearly 9%.

Amarin's Vascepa Gets 3-Year Exclusivity - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 4:20PM CST
Amarin announced that Vascepa was given 3 years of marketing exclusivity by FDA in connection with the MARINE indication.

Vertex' Kalydeco Approved for an Additional Indication - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 12:00PM CST
Vertex Pharma received encouraging news when the FDA approved Kalydeco for an additional indication.

Encouraging Data on Bristol-Myers/Pfizer's Eliquis - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 10:50AM CST
Eliquis performed encouragingly in a late stage study.

Retrophin (RTRX) Jumps: Stock Moves 14.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 8:46AM CST
Retrophin was a big mover last session, with shares rising over 14%.

Stemline Therapeutics (STML) Worth Watching: Stock Rises 8.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 8:25AM CST
Stemline Therapeutics was a big mover last session, with shares rising over 8%.

Should You Get Rid of WellCare (WCH) Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 7:58AM CST
WellCare has witnessed a significant price decline in the past four weeks with negative earnings estimate revisions for the current quarter and the current year

Bayer Progresses with Stivarga - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 4:00PM CST
Bayer announced the commencement of the patient enrolment process for a phase III study on Stivarga.

Raptor Soars on Positive RP103 Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 3:30PM CST
Raptor soared almost 14.9% after the company announced encouraging results from a study on RP103.

Omeros Doses First Patient in a Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 5:00PM CST
Omeros announced that the first patient has been dosed in a second phase II study on candidate, OMS824

Pipeline Progress at Bayer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 4:00PM CST
Bayer announced the initiation of the phase III EINSTEIN CHOICE study on Xarelto.

The Medicines Co Posts Lower Y/Y Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 9:40AM CST
The Medicines Co.'s fourth-quarter earnings of 26 cents per share were well below the year-ago earnings of 52 cents per share.

Actelion Ltd (ALIOF) Stock Research Links

ALIOF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 280

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Envision and ju:niz Boost Germany's Energy Storage

Updated Category News Views 85

Germany Charges Ahead with Renewable Energy Storage Germany's on a mission, folks, and it's all about beefing up their renewable energy infrastructure. Out in Bavaria, Envision Energy and ju:niz Energy are prepping a significant leap forward. They're rolling out a big undertaking—a 442 MWh battery energy storage system (BESS) with their Smareg 13 project in Vöhringen....

Continue Reading
NextVision's Q3 2026: Impressive Growth and Expansion

Updated Category News Views 98

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Continue Reading
Next Bridge Hydrocarbons' Call for Presidential Intervention

Updated Category News Views 25

Trump's New Team: A Hope for Shareholder Relief? Picture the scene—Next Bridge Hydrocarbons, caught in the depths of shareholder unrest over the unresolved MMTLP fiasco, is looking to the top for answers. With a fresh face, Stephen Miller, stepping in as the White House Chief of Staff, there's a new angle at play. They're knocking on the doors of the Trump...

Continue Reading
Nevada Organic Phosphate Plans Share Consolidation

Updated Category News Views 31

The Drill Down on Nevada Organic Phosphate's Strategic Moves There's a lot to unpack here as Nevada Organic Phosphate Inc. (CSE: NOP) rolls out its big game plan. They're looking to consolidate shares, flex their financial muscles, and maybe spray some high-octane fuel on their market positioning. Could be a smart move if they pull it off, but that's a big 'if' hanging in...

Continue Reading
Protalix Unveils Promising Gout Therapy Data at ACR 2026

Updated Category News Views 31

A Glimmer of Hope for Gout Sufferers Uncontrolled gout patients may soon see a light at the end of the tunnel. Protalix BioTherapeutics (NYSE American: PLX) just rolled out data at the ACR Convergence 2026, underscoring the potential of their drug candidate, PRX-115. This revelation is a big deal for those grappling with gout that just won't quit, constantly pelted by...

Continue Reading
West Virginia's Water Upgrade: AWK's Strategic Moves

Updated Category News Views 55

Building a Water Infrastructure with Purpose Well, they ain't just whistling Dixie down in Ranson, West Virginia. American Water's been busy putting their money where their mouth is with this new 816,000-gallon tank. When you look at the bigger picture, it ain't just about a shiny new water storage toy. Nah, this is about setting the stage for long-term resilience in the...

Continue Reading
Spatial Genomics Market Set for Major Expansion by 2031

Updated Category News Views 69

The Rise of Spatial Genomics You’ve got to hand it to the science behind spatial genomics and transcriptomics—this arena’s not just on a hot streak; it’s scorching. We’re staring down the barrel of a market raring to more than double in value, surging from a worth of USD 0.67 billion in 2026 straight to the big USD 1.23 billion in 2031. The CAGR that’s...

Continue Reading
OpenHear BM420: CES 2027 Honoree for Accessibility

Updated Category News Views 58

Shokz's Big Leap With OpenHear BM420 Alright, this recognition for Shokz comes out of the left field for anyone not keeping an eye on their trajectory lately. From headphones to hearing aids—Shokz takes a genuine shot at making life easier for folks struggling with hearing issues. The CES 2027 Innovation Award for their OpenHear BM420 shows the tech's real potential in...

Continue Reading
Philips Avent Unveils Innovative Glass Baby Bottle Design

Updated Category News Views 72

A New Take on Baby Bottles: Meet the Philips Avent Natural Here's something to perk your ears if you've been navigating the parenting world with arms full of gear—Philips Avent has hit the market with a new glass baby bottle that's shaking things up. Now, we're not talking about superficial bells and whistles like fancy colors or quirky shapes. Nope, Philips knows that...

Continue Reading

Top 5 Most Recently Viewed Articles

DENTSPLY SIRONA's Future: Insights and Market Trends Explored

Updated Category News Views 255

Piper Sandler confirmed its neutral outlook on DENTSPLY SIRONA (NASDAQ: XRAY) with a price target of $32.00 back in late 2024. This comes after the firm attended the company’s DS World event, which featured a heavy focus on the Primescan 2 dental scanner. The scanner aims to integrate advanced digital solutions for dental practices, but can it really turn the tide amid...

Continue Reading
CVS Health to Pay $37.8 Million Over Improper Insulin Claims

Updated Category News Views 173

CVS Health Under Scrutiny for Insulin Billing Practices In a significant legal development, CVS Health Inc. has been accused of engaging in several years of improper billing related to insulin refills. This allegation was put forth by federal prosecutors, highlighting the pressing concerns over healthcare fraud in the system. Settlement and Allegations of Fraud The U.S....

Continue Reading
EPRT Reaches Record High with Stellar Growth Ahead

Updated Category News Views 103

EPRT Achieves Record High with Strong Performance Essential Properties Realty Trust (NYSE: EPRT) has reached a significant milestone, hitting an all-time high of $33.95 per share. This increase reflects an impressive annual growth rate of 44.46%, highlighting the confidence that investors have in the REIT’s portfolio and its ability to generate steady rental income....

Continue Reading
Support for Identity Theft Victims During Federal Shutdown

Updated Category News Views 239

Continuous Support for Identity Theft Victims The Identity Theft Resource Center (ITRC) is committed to assisting individuals who have fallen victim to identity theft, fraud, or scams. As the challenges of identity crime continue to rise, the ITRC stands as a beacon of hope and support in these trying times. What Is the Identity Theft Resource Center? The ITRC is a...

Continue Reading
PayPal Elevates Financial Game with New Bank Charter Initiative

Updated Category News Views 204

PayPal Moves Forward with Bank Charter Application PayPal Holdings, Inc. is seeing increased trading activity after announcing its plans to establish PayPal Bank. This decision hints at broader ambitions within the finance sector, as the company seeks to apply for a banking charter that would allow it to directly provide small business loans and federally insured savings...

Continue Reading